Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Cannabis in Rheumatology Care: A Look at the Latest Research & What Rheumatologists Are Telling Their Patients

Carina Stanton  |  Issue: April 2018  |  March 26, 2018

“Can marijuana help me?”

Barbara Goldstein, MD, MMSc, hears this question from patients throughout the day, every day. And she has noticed an increase in the number of patients asking it since 2014, when marijuana was legalized for anyone over the age of 21 to purchase in Colorado.1 Her answer is the same for each patient: “We just don’t have enough reliable data to suggest cannabinoid use for patients.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Goldstein worries that inhaled cannabis poses an antigen risk to the lungs and that cannabis edibles vary dramatically in dosing and the tetrahydrocannabinol (THC) content responsible for its mind-altering effects. “Topicals may be safe and effective, but we just don’t have clinical trials and reliable preparations. I tell my patients all of this and that they have to use it at their own risk.

“What we need are trials that are conducted using scientific methods, are hypothesis driven and [use a] placebo or comparator product,” she suggests. “Then we can review the information and decide how clinically relevant and generalizable [medicinal cannabis] really is.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Some rheumatologists are taking a different approach. Jeff Peterson, MD, also shares his hope for clinical data on cannabis applications for patients with rheumatic diseases.

With this lack of data and faced with daily requests from patients about incorporating cannabis into their treatment, Dr. Peterson took a trip to a local, high-end pot shop in Washington, where marijuana become legal to sell in 2014.2 His goal was to understand what his patients were hearing from marijuana retailers. He learned how this retailer talks to customers about some of the common chemical compounds in recreational marijuana, including THC vs. cannabidiol (CBD), and received an education on different forms of marijuana, including edibles, tinctures and topical creams and ointments.

Dr. Peterson has also learned anecdotally about the perceived efficacy of marijuana from patients choosing to try it in different forms. The majority of his patients who use cannabis choose the topical cream or ointment to manage pain and find it helpful. But they note that the preparation—the dose and combination of THC/CBD—does make a difference. His patients who use a tincture form that is placed on the tongue report that it is effective for moderate relief of insomnia and anxiety, particularly among his patients with fibromyalgia. But these patients also note a difference with the dose and combination of THC/CBD.

Although Dr. Peterson puts himself on the more holistic side of the rheumatology spectrum, he feels his patients deserve to be empowered with whatever knowledge is available and would prefer his patients feel comfortable talking to him about what they are using to complement their traditional treatment.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Drug Updates Tagged with:cannabinoidcannabisLegalmarijuana

Related Articles

    Cannabis for Pain Relief: An Area Ripe for Research

    September 28, 2023

    Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

    Cannabinoids Show Potential in Pain Management

    February 13, 2020

    ATLANTA—The potential of cannabis‐based medicines is a hot topic, particularly as pain management therapy for arthritis and other conditions. However, confusion abounds regarding its therapeutic potential, how it can be administered and even the correct terminology to use. David P. Finn, PhD, professor of pharma­cology and therapeutics, and founding co-director of the Centre for Pain…

    Brandon Crawford / shutterstock.com

    Case Report: Blunt Smoker Denies Tobacco Use, Delaying Diagnosis

    May 12, 2022

    Cannabis arteritis mirrors thrombo­angiitis obliterans in its clinical and arteriographic presentation, but its relevant exposure is cannabis rather than tobacco.1 Whether cannabis arteritis is a subset of thromboangiitis obliterans or a unique pathologic entity is debatable. Delta-9-tetrahydrocannabinol, the primary psychoactive component of cannabis, is a peripheral vasoconstrictor.2 This offers mechanistic insight into how cannabis may…

    Marijuana for Rheumatology Patients?

    February 17, 2018

    SAN DIEGO—What does cannabis offer to the treatment and management of rheumatology patients and the range of pain states they experience? What do we really know about its long-term effects? These are hard questions to answer with currently available data and a reality nuanced by complications cannabis advocates don’t always recognize, according to two experts…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences